ArticleMolecular cancer therapeutics2018

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.

Yemin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.